NEW YORK – September 28, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced that senior management will participate in the following investor conferences in October. William Blair Virtual Radiopharma Conference...
Executive with three decades of successful multinational operations and commercial experience to lead launch of proprietary radioisotope production platform VALENCIA, Calif. – Sept. 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting...
News from the United Kingdom’s Institute of Cancer Research (ICR) published in The Lancet Oncology reports that targeted radiation treatment is “greatly improving” the quality of life for cancer patients. ICR writes: Patients with advanced prostate...
With many now expecting radiopharamaceuticals to grow into a $20-30 billion market, investors are increasingly looking at the obstacles and opportunities for suppliers and drugmakers in this space. To advance these discussions, on Friday, May 12, 2023, Nusano and...
VALENCIA, Calif. – July 20, 2023 – Nusano, Inc., a company working to stabilize and enable the production of cancer-fighting radioisotopes, today announced participation in two conferences in July 2023. Nusano CEO Chris Lowe will present an overview of the company’s...